Live at NCVH 2026 — hands-on with the latest in peripheral intervention.
We’re showcasing the new **Crosslead Tracker and Penetration wires** (excellent tracking in tortuosity, controlled cap engagement, and strong device support).
Highlight of the week: Our official Asahi Intecc Lunch Symposium “It’s Time! Transforming PAD and CLTI Care from Top to Toe”
📍 Wednesday, May 27 • 12:00 – 1:00 PM
📍 Waldorf Ballroom
Host: Dr. Craig Walker
Keynote Speaker: Mr. Masahiko Miyata (Chairman & Founder, Asahi Intecc)
Speakers: Dr. Ashwani Sastry, Dr. Jay Mathews, Dr. Osama Ibrahim
Fellows, attendings, and lab teams — what PAD/CLTI topics do you hope they cover? Drop your thoughts or questions below 👇
#NCVH2026#Crosslead#AsahiMedEd#PeripheralIntervention#CLTI#PAD#MedEd
Celebrating an extraordinary career—congratulations to Kenneth Rosenfield, MD, MHCDS, MSCAI, recipient of the Helping Hearts Lifetime Service Award at #SCAI2026 🎉👏
A past SCAI President, his leadership, innovation, and lasting contributions have helped shape vascular and interventional medicine and improve patient care worldwide.
@SrihariNaiduMD@sahilparikhmd
60 y/o with unknown thrombophilia on AC since 1990's. He was admitted to our sister hosp 3 weeks ago with syncope, extreme pain, and severe bilateral swelling. He went off DOACs 2 months prior due to cost. Had also prior Optease in 2017 for unclear indication. An adventure begins
Patient reports resolution of pain and LE swelling. Patient refusing enoxaparin so back on DOAC. Expensive and time consuming case but good outcome. Multimodality approach is sometimes key with mixed morphology clot. @NCVHonline@VIVAPhysicians@ISETNews@_backtable@WLGore
It is feasible to fracture mechanical valve leaflets using commercially available angioplasty balloons. Cracking the carbon ring requires substantially higher pressure.
Get the details: jacc.org/doi/10.1016/j.jcin.…#JACCINT